©2026 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy

Contributor:

Marguerite B. McDonald, MD, FACS

Marguerite McDonald, MD
Marguerite McDonald, MD

Abnormal Tear Osmolarity Prevalence
Abnormal Tear Osmolarity Prevalence

Marguerite McDonald, MD

Hot Topic: Results of the DREAM study
Hot Topic: Results of the DREAM study

Eric D. Donnenfeld, MD, John D. Sheppard, MD, Lisa M. Nijm, MD, JD, Marguerite McDonald, MD

Complex Case Discussions at AECOS
Complex Case Discussions at AECOS

Marguerite B. McDonald, MD, FACS; and Brandon Ayres, MD

How to Classify Presbyopia by Severity
How to Classify Presbyopia by Severity

Marguerite McDonald, MD, FACS; and Neda Shamie, MD

ICL in Marfan Syndrome
ICL in Marfan Syndrome

Marguerite B. McDonald, MD, FACS; and Brian Szabo, DO

Celebrating the 30th Anniversary of LASIK
Celebrating the 30th Anniversary of LASIK

Eric D. Donnenfeld, MD, Marguerite McDonald, MD, FACS, Robert K. Maloney, MD

Pearls From a Senior Ophthalmologist to a Young Ophthalmologist
Pearls From a Senior Ophthalmologist to a Young Ophthalmologist

Marguerite McDonald, MD

Dr. McDonald Shares Her Surgical Case and Postoperative Treatment Insights Following Cataract Surgery
Dr. McDonald Shares Her Surgical Case and Postoperative Treatment Insights Following Cataract Surgery

Marguerite McDonald, MD, FACS

The Secret Sauce in the Cryopreserved Amniotic Membrane
The Secret Sauce in the Cryopreserved Amniotic Membrane

Marguerite McDonald, MD, FACS

Innovations in …Mydriasis?
Innovations in …Mydriasis?

I. Paul Singh, MD; and Marguerite McDonald, MD, FACS

Advanced Features of the Systane<sup>®</sup> iLux2<sup>®</sup> System
Advanced Features of the Systane® iLux2® System

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

First-Line Treatment for Meibomian Gland Dysfunction
First-Line Treatment for Meibomian Gland Dysfunction

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

Clinical Data From the Systane<sup>®</sup> iLux2<sup>®</sup> System
Clinical Data From the Systane® iLux2® System

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

What Makes the Systane<sup>®</sup> iLux2<sup>®</sup> Different From Traditional Heat Therapy?
What Makes the Systane® iLux2® Different From Traditional Heat Therapy?

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

Improve Meibomian Gland Function and Tear Film Stability With Systane<sup>®</sup> iLux2<sup>®</sup>
Improve Meibomian Gland Function and Tear Film Stability With Systane® iLux2®

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

Clinical Data From the Systane<sup>®</sup> iLux2<sup>®</sup>System After 1 Year
Clinical Data From the Systane® iLux2®System After 1 Year

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

Exploring the Future of Corneal Surgery

Marguerite B. McDonald, MD, FACS; George O. Waring IV, MD, FACS; Marcela Feltrin de Barros, MD; and Steven E. Wilson, MD, FARVO

Managing Patients Who Have a History of Radial Keratotomy or Early LASIK

Parag Majmudar, MD; Bret L. Fisher, MD; Hercules Logothetis, MD; and Marguerite B. McDonald, MD, FACS